Pitcairn’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-4,226
| Closed | -$338K | – | 104 |
|
|
2025
Q3 | $338K | Sell |
4,226
-5,589
| -57% | -$477K | 0.03% | 466 |
|
|
2025
Q2 | $892K | Sell |
9,815
-998
| -9% | -$91.1K | 0.06% | 283 |
|
|
2025
Q1 | $1.01M | Buy |
10,813
+61
| +0.6% | +$5.46K | 0.06% | 268 |
|
|
2024
Q4 | $977K | Buy |
10,752
+364
| +4% | +$34.7K | 0.06% | 268 |
|
|
2024
Q3 | $1.08M | Buy |
10,388
+787
| +8% | +$80.2K | 0.06% | 259 |
|
|
2024
Q2 | $932K | Buy |
9,601
+1,697
| +21% | +$157K | 0.06% | 284 |
|
|
2024
Q1 | $712K | Buy |
7,904
+795
| +11% | +$67.4K | 0.05% | 326 |
|
|
2023
Q4 | $567K | Sell |
7,109
-157
| -2% | -$11.8K | 0.04% | 365 |
|
|
2023
Q3 | $517K | Buy |
7,266
+380
| +6% | +$28.4K | 0.04% | 348 |
|
|
2023
Q2 | $530K | Buy |
6,886
+88
| +1% | +$6.81K | 0.04% | 343 |
|
|
2023
Q1 | $511K | Buy |
6,798
+115
| +2% | +$8.55K | 0.05% | 334 |
|
|
2022
Q4 | $527K | Buy |
6,683
+227
| +4% | +$17K | 0.05% | 309 |
|
|
2022
Q3 | $454K | Buy |
6,456
+18
| +0.3% | +$1.41K | 0.05% | 307 |
|
|
2022
Q2 | $516K | Buy |
6,438
+407
| +7% | +$31.8K | 0.05% | 292 |
|
|
2022
Q1 | $457K | Buy |
6,031
+348
| +6% | +$27.6K | 0.04% | 386 |
|
|
2021
Q4 | $485K | Buy |
5,683
+124
| +2% | +$9.68K | 0.03% | 381 |
|
|
2021
Q3 | $420K | Sell |
5,559
-397
| -7% | -$31.5K | 0.03% | 399 |
|
|
2021
Q2 | $484K | Buy |
5,956
+148
| +3% | +$12.1K | 0.03% | 357 |
|
|
2021
Q1 | $458K | Buy |
5,808
+123
| +2% | +$9.64K | 0.03% | 353 |
|
|
2020
Q4 | $486K | Buy |
5,685
+101
| +2% | +$8.35K | 0.04% | 294 |
|
|
2020
Q3 | $431K | Buy |
5,584
+241
| +5% | +$18.4K | 0.04% | 271 |
|
|
2020
Q2 | $391K | Buy |
5,343
+70
| +1% | +$4.97K | 0.04% | 280 |
|
|
2020
Q1 | $350K | Buy |
5,273
+368
| +8% | +$26K | 0.04% | 260 |
|
|
2019
Q4 | $337K | Sell |
4,905
-163
| -3% | -$11.1K | 0.03% | 350 |
|
|
2019
Q3 | $372K | Sell |
5,068
-689
| -12% | -$50K | 0.04% | 316 |
|
|
2019
Q2 | $412K | Buy |
5,757
+924
| +19% | +$65.6K | 0.04% | 287 |
|
|
2019
Q1 | $331K | Sell |
4,833
-67
| -1% | -$4.33K | 0.04% | 324 |
|
|
2018
Q4 | $291K | Sell |
4,900
-67
| -1% | -$4.19K | 0.03% | 313 |
|
|
2018
Q3 | $332K | Sell |
4,967
-113
| -2% | -$7.53K | 0.03% | 376 |
|
|
2018
Q2 | $329K | Sell |
5,080
-194
| -4% | -$12.7K | 0.04% | 369 |
|
|
2018
Q1 | $378K | Sell |
5,274
-823
| -13% | -$59.2K | 0.04% | 305 |
|
|
2017
Q4 | $460K | Buy |
6,097
+117
| +2% | +$8.54K | 0.05% | 278 |
|
|
2017
Q3 | $435K | Sell |
5,980
-273
| -4% | -$19.7K | 0.05% | 281 |
|
|
2017
Q2 | $464K | Buy |
6,253
+67
| +1% | +$4.97K | 0.06% | 250 |
|
|
2017
Q1 | $453K | Sell |
6,186
-298
| -5% | -$20.9K | 0.05% | 268 |
|
|
2016
Q4 | $424K | Sell |
6,484
-208
| -3% | -$14.3K | 0.05% | 283 |
|
|
2016
Q3 | $496K | Buy |
6,692
+28
| +0.4% | +$2.07K | 0.06% | 248 |
|
|
2016
Q2 | $488K | Buy |
6,664
+50
| +0.8% | +$3.56K | 0.06% | 229 |
|
|
2016
Q1 | $467K | Buy |
6,614
+183
| +3% | +$12.2K | 0.06% | 247 |
|
|
2015
Q4 | $428K | Sell |
6,431
-324
| -5% | -$21.6K | 0.05% | 267 |
|
|
2015
Q3 | $429K | Buy |
6,755
+647
| +11% | +$42.3K | 0.06% | 261 |
|
|
2015
Q2 | $399K | Sell |
6,108
-55
| -0.9% | -$3.73K | 0.05% | 303 |
|
|
2015
Q1 | $427K | Buy |
6,163
+5
| +0.1% | +$346 | 0.05% | 296 |
|
|
2014
Q4 | $426K | Buy |
6,158
+46
| +0.8% | +$3.11K | 0.05% | 273 |
|
|
2014
Q3 | $398K | Hold |
6,112
| – | – | 0.04% | 303 |
|
|
2014
Q2 | $417K | Sell |
6,112
-60
| -1% | -$4.02K | 0.05% | 286 |
|
|
2014
Q1 | $400K | Sell |
6,172
-1,930
| -24% | -$122K | 0.04% | 294 |
|
|
2013
Q4 | $529K | Sell |
8,102
-81
| -1% | -$5.18K | 0.06% | 243 |
|
|
2013
Q3 | $485K | Sell |
8,183
-260
| -3% | -$15.4K | 0.06% | 241 |
|
|
2013
Q2 | $484K | Buy |
+8,443
| New | +$501K | 0.06% | 251 |
|
Other funds holding CL
Pitcairn's CL Position: Q4 2025 in Review
Pitcairn sold out of Colgate-Palmolive (CL) in Q4 2025, closing a stake of 4,226 shares — an estimated $338K sold.
Pitcairn first reported a position in CL in Q2 2013 and held it in 50 quarters. The position peaked at $1.08M in Q3 2024. 1,887 funds tracked by Wall St. Rank hold CL as of Q4 2025.
- Pitcairn reported no remaining Colgate-Palmolive position as of Q4 2025 after selling out during the quarter.
- Pitcairn sold 4,226 Colgate-Palmolive shares in Q4 2025, an estimated $338K.
- Pitcairn first reported a position in Colgate-Palmolive in Q2 2013 and held it in 50 quarters.
- Pitcairn's Colgate-Palmolive position peaked at $1.08M in Q3 2024.
- 1,887 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2025.
Based on Pitcairn's 13F filing for Q4 2025.